The global dyslipidemia therapeutics market is valued at US$ 41.55 billion in 2023 and is forecasted to exhibit expansion at a CAGR of 2.5% over the next ten years. This Fact.MR market study predicts global demand for dyslipidemia therapeutics to accumulate a market revenue of US$ 53.2 billion by the end of 2033.The dyslipidemia therapeutics market encompasses a range of...